MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy. [electronic resource]
Producer: 20200706ISSN:- 1573-4935
- 3' Untranslated Regions -- genetics
- Albumins -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Base Sequence
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Drug Resistance, Neoplasm -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- HEK293 Cells
- Humans
- Kaplan-Meier Estimate
- Male
- MicroRNAs -- genetics
- Outcome Assessment, Health Care -- methods
- Oxaliplatin -- administration & dosage
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- diagnosis
- Ribonucleoside Diphosphate Reductase -- genetics
- Sequence Homology, Nucleic Acid
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.